IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | Před 1022 dny
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | Před 573 dny
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | Před 756 dny
South Korea Import, Export Price Data Due On Tuesday

South Korea Import, Export Price Data Due On Tuesday

South Korea will on Tuesday see August numbers for import and export prices, highlighting a light day for Asia-Pacific economic activity. In July, import prices were down 5.9 percent on year and export prices fell an annual 4.3 percent.
RTTNews | Před 1 h 0 min
South Korea Export Prices Rise 0.7% In August

South Korea Export Prices Rise 0.7% In August

Export prices in South Korea were up a seasonally adjusted 0.7 percent on month in August, the Bank of Korea said on Tuesday - after adding 0.8 percent in July.
RTTNews | Před 1 h 30 min
U.S. Dollar Falls Before Fed Decision

U.S. Dollar Falls Before Fed Decision

The U.S. dollar weakened against its major counterparts in the New York session on Monday, ahead of the Federal Reserve's policy decision on Wednesday.
RTTNews | Před 1 h 38 min
Swiss Market Ends Weak After Choppy Ride

Swiss Market Ends Weak After Choppy Ride

The Switzerland market ended on a weak note on Monday after spending much of the day's session in negative territory, as investors stayed wary of picking up stocks, choosing to wait for some clear directional clues.
RTTNews | Před 4 h 24 min
European Markets Close Mostly Higher Ahead Of Central Bank Policy Meetings

European Markets Close Mostly Higher Ahead Of Central Bank Policy Meetings

The markets in Europe closed mostly higher on Monday, although the UK market underperformed and settled slightly lower. Investors digested a batch of regional economic data, and looked ahead to the monetary policy announcements from the Federal Reserve, the Bank of England the Bank of Japan due later in the week.
RTTNews | Před 4 h 44 min
Canadian Market Modestly Higher; Energy, Materials Stocks Rise

Canadian Market Modestly Higher; Energy, Materials Stocks Rise

The Canadian market is up in positive territory Monday afternoon, with stocks from energy, materials, technology and consumer discretionary sectors contributing to the upmove. The mood remains cautious with investors looking ahead to interest rate decisions from the Bank of Canada and the Federal Reserve on Wednesday.
RTTNews | Před 6 h 11 min